Elanco Animal Health Total Liabilities
Elanco Animal Health total liabilities. Based on the latest financial reports, Elanco Animal Health (ELAN) has total liabilities worth $6.97 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ELAN asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Elanco Animal Health (2016–2025)
Total liabilities of Elanco Animal Health from 2016 to 2025. This chart illustrates how Elanco Animal Health's total liabilities have evolved over time, based on quarterly financial data. Explore Elanco Animal Health (ELAN) long-term investment share to see how much of total assets are deployed in long-term investments.
Elanco Animal Health Competitors by Total Liabilities
The table below lists competitors of Elanco Animal Health ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Covestro AG
XETRA:1COV
|
Germany | €7.11 Billion |
|
Korea Shipbuilding & Offshore Engineering Co Ltd
KO:009540
|
Korea | ₩27.80 Trillion |
|
Tempus AI, Inc. Class A Common Stock
NASDAQ:TEM
|
USA | $1.92 Billion |
|
WOORI FIN. GRP SP.ADR/3
F:2WGA
|
Germany | €563.60 Trillion |
|
CSPC PHARMACEUT.GR. ADR4
F:CVGU
|
Germany | €16.59 Billion |
|
First Horizon Corporation
NYSE:FHN
|
USA | $74.97 Billion |
|
REXEL S.A. ADR EO 5
F:E7V0
|
Germany | €8.96 Billion |
|
Novatek Microelectronics Corp
TW:3034
|
Taiwan | NT$31.74 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Elanco Animal Health's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Elanco Animal Health.
Liquidity & Leverage Metrics
Elanco Animal Health Total Liabilities Ratios Explained
Elanco Animal Health total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Elanco Animal Health's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Elanco Animal Health (2016–2025)
The table below shows the annual total liabilities of Elanco Animal Health from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $6.81 Billion | +4.50% |
| 2024-12-31 | $6.52 Billion | -19.92% |
| 2023-12-31 | $8.14 Billion | -0.77% |
| 2022-12-31 | $8.20 Billion | -8.56% |
| 2021-12-31 | $8.97 Billion | -2.68% |
| 2020-12-31 | $9.22 Billion | +168.02% |
| 2019-12-31 | $3.44 Billion | -8.52% |
| 2018-12-31 | $3.76 Billion | +227.03% |
| 2017-12-31 | $1.15 Billion | +7.25% |
| 2016-12-31 | $1.07 Billion | -- |
About Elanco Animal Health
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide … Read more